Recombinant Human PTPRM Protein，GST

PTPRM (Protein Tyrosine Phosphatase Receptor Type M) is a member of the receptor-type protein tyrosine phosphatase family, which plays crucial roles in various cellular processes, including cell signaling, adhesion, and differentiation. Its involvement in regulating tyrosine phosphorylation makes it a key player in cancer biology and other diseases. Dysregulation of PTPRM has been associated with several types of cancer, suggesting that it may serve as a potential tumor suppressor. Researchers have focused on the structural and functional aspects of PTPRM to better understand its role in cellular signaling pathways. Recombining this protein allows for detailed studies of its enzymatic activity, interaction with substrates, and impact on tumor progression. Advances in recombinant protein technology have facilitated the production of active PTPRM variants, enabling scientists to explore its therapeutic potential. Understanding the mechanisms governed by PTPRM could lead to novel strategies for cancer treatment and provide insights into the intricate networks of signaling involved in cell behavior. Thus, the study of recombinant PTPRM is not only vital for elucidating its biological functions but also holds promise for developing targeted therapies that leverage its regulatory capabilities in disease contexts.